Results 191 to 200 of about 1,686,994 (258)

Unmasking Celiac Disease Through Chronic Urticaria: Case Report and Scoping Review. [PDF]

Nutrients
Cappozzo F, Schrempp Esteves C, Corsolini F, Lacovara A, Pastorino J, Naso M, Ferro J, Malerba F, Bonassi S, Crocco M.   +9 more
europepmc   +1 more source

Aseptic meningitis due to intravenous immunoglobulin therapy (IVIG) in therapy‐refractory pyoderma gangraenosum

JDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.
Katharina A. Kälber, Knut Schäkel, Alexander Enk, Julia K. Winkler   +3 more
wiley   +1 more source

Management of chronic urticaria: Current status and future prospect

Journal of the European Academy of Dermatology and Venereology, EarlyView.
Chronic urticaria is driven by mast cell activation through autoimmune, inflammatory, and neuroimmune pathways. A structured approach combining diagnosis, patient‐reported outcomes, stepwise therapy, treatment optimization, monitoring and emerging targeted agents may improve disease control and enable more personalized management.
Andaç Salman, Mona Al‐Ahmad, Maryam Al‐Nesf, Chia‐Yu Chu, Luis Felipe Ensina, Ana M. Gimenez‐Arnau, Margarida Gonçalo, Clive Grattan, Michihiro Hide, Pavel Kolkhir, Martin Metz, Iman Nasr, Romi Saini, Simon Francis Thomsen, Torsten Zuberbier, Emek Kocaturk   +15 more
wiley   +1 more source

Population-Based Incidence of Acute and Chronic Urticaria in Southern California: 2017-2022. [PDF]

Perm J
Jean T, Yim HJ, Chu V, Zhang J, Sheikh J, Samant S, Macy E.   +6 more
europepmc   +1 more source

Eight Years of Citizen Science Reveal Taxonomic Confusion Patterns and Dynamic Participation in the Monitoring of Vespa velutina in Spain

Journal of Applied Entomology, EarlyView.
ABSTRACT The yellow‐legged hornet (Vespa velutina nigrithorax) is a successful invasive species in Europe, where its monitoring is partially reliant on citizen science (CS) initiatives. While CS is a powerful tool for early detection, taxonomic confusion and fluctuating participant engagement can limit its effectiveness.
Cayetano Herrera, Carlos Guerrero, Joan Amengual, Gabriel Arbona, Mar Leza   +4 more
wiley   +1 more source

Why physicians underuse patient-reported outcomes in atopic dermatitis and chronic urticaria - Insights from the UCARE/ADCARE PROMUSE study. [PDF]

World Allergy Organ J
Cherrez-Ojeda I, Robles-Velasco K, Giménez-Arnau A, Godse K, Krasowska D, Bartosińska J, Szczepanik-Kułak P, Wawrzycki B, Kolkhir P, Allenova A, Allenov A, Tkachenko S, Mitrevska NT, Mijakoski D, Stoleski S, Kolacinska-Flont M, Kuprys-Lipinska I, Molinska J, Kasperska-Zając A, Zajac M, Zamlynski M, Mihaltan F, Ulmeanu R, Zalewska-Janowska A, Tomaszewska K, Al-Ahmad M, Al-Nesf MA, Abhs M, Ibrahim T, Agel S, Pesqué D, Rodríguez-González M, Wakida-Kuzunoki GH, Ramon GD, Ramon GN, Neisinger S, Bonnekoh H, Rukhadze M, Khoshkhui M, Aliabadi MM, Fomina D, Larenas-Linnemann D, Košnik M, Kara RO, Caballero López CG, Liu Q, Ivancevich JC, Ensina LF, Rosario N, Kvedariene V, Ben-Shoshan M, Jardim Criado RF, Bauer A, Cherrez A, Chong-Neto H, Rojo-Guierrez MI, Rudenko M, Larco Sousa JI, Lesiak A, Matos E, Muñoz N, Moreno J, Tinoco I, Faytong-Haro M, Bousquet J, Zuberbier T.   +65 more
europepmc   +1 more source

Early Changes in Lymphocyte Counts Predict Clinical Outcomes in Hepatocellular Carcinoma Treated With Durvalumab Plus Tremelimumab

Journal of Gastroenterology and Hepatology, EarlyView.
ABSTRACT Background Durvalumab plus tremelimumab (Dur/Tre) has shown promising efficacy in advanced hepatocellular carcinoma (HCC), but predictive biomarkers remain unclear. This study aimed to determine whether early changes in peripheral blood lymphocyte counts during Dur/Tre therapy can predict clinical outcomes.
Yuichi Honma, Shigeo Shimose, Takanori Ito, Issei Saeki, Joji Tani, Takanori Matsuura, Tetsu Tomonari, Yasuto Takeuchi, Nobuhito Taniki, Kyo Sasaki, Ryu Sasaki, Takeshi Hatanaka, Satoru Kakizaki, Naoki Yoshioka, Takehito Naito, Mamiko Takeuchi, Tetsuya Yasunaka, Masahiro Sakata, Hideki Iwamoto, Tomotake Shirono, Satoshi Itano, Norikazu Tanabe, Takafumi Yamamoto, Atsushi Naganuma, Yuki Kanayama, Hisamitsu Miyaaki, Sohji Nishina, Nobuhiro Nakamoto, Motoyuki Otsuka, Tetsuji Takayama, Yuzo Kodama, Hideki Kobara, Taro Takami, Hiroki Kawashima, Takumi Kawaguchi, Masaru Harada, Hepatology InVestigator Experts in Japan (HIVE‐J) Study Group   +36 more
wiley   +1 more source

Emerging IgE and non-IgE targeted therapies for chronic urticaria. [PDF]

Ann Allergy Asthma Immunol
Chhiba KD, Saini SS.
europepmc   +1 more source

From Social Justice to Indigenous Peoples' Rights: Continuities and (Re)framings in Ejido Property Claims in Yucatán, Mexico

Journal of Agrarian Change, EarlyView.
ABSTRACT This article examines how long‐standing local conflicts concerning the nature of common property, the distribution of access and administrative rights associated with it, and more broadly the nature of the community and the forms of citizenship that organise its governance shape demands for justice regarding land transfers to outside investors
Eric Léonard, Kelly Redouté, María Gabriela Durán Valis   +2 more
wiley   +1 more source

Clinical phenotypes and molecular endotypes of chronic urticaria: Linking clinical expression to underlying immune mechanisms. [PDF]

Asia Pac Allergy
Türk M, Bizjak-Suran M, Can PK, Criado PR, Fluhr JW, Özceker D, Pawankar R, Pyatilova P, Salman A, Sánchez J, Tuncay G, Xiang YK, Yücel MB, Kocatürk E.   +13 more
europepmc   +1 more source